Online
I think the run in tech shows there’s money everywhere looking to work. This kind of info could fuel a mini-run into the start of the school year.
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: this_feature_currently_requires_accessing_site_using_safari
I picked up PFE a while ago, but before their second dip.. so I'm in the red still. I think it was April or May, but I"d have to look it up.I added a Pfizer (PFE) position two weeks ago. I think it's a quality portfolio stock at this point. It's still almost 10% below February level, which means there's more to go. It's up about 7% since I bought it, now trading at just under $37.
I like that it pays a 4+ percent dividend. And Pfizer is quietly working on a Covid vaccine with BioNTech (BNTC) that, according to published information, anticipates stronger T-cell response than Moderna's effort. It's way too early to know how any of these vaccine candidates are going to pan out but with Pfizer, you get a company with a strong legacy business, a nice dividend, and still room to gain purely on the company's pre-Covid work.
I might add more if there's a dip.
LYV reports tomorrow. Consensus is down 91.4% for them but I'm not sure it doesn't go over 100%. The first quarter was terrible for them but people were not requesting refunds, something like 90% of people opted to just hold the tickets for a to be determined date. Now that it is obvious there will be no concerts until 2021 and sporting events pretty much known to be fanless nationwide, I'm thinking the refunds are probably going to make them miss even then 91%.AAL reports Q2 after the bell. The consensus revenue is down 87% from Q2 2019. Yikes.
LYV reports tomorrow. Consensus is down 91.4% for them but I'm not sure it doesn't go over 100%. The first quarter was terrible for them but people were not requesting refunds, something like 90% of people opted to just hold the tickets for a to be determined date. Now that it is obvious there will be no concerts until 2021 and sporting events pretty much known to be fanless nationwide, I'm thinking the refunds are probably going to make them miss even then 91%.
I'm getting the feeling that airlines are going to be a huge buy after they get through Q2 earnings and the second flight data starts to tick back up.
Ive got cheap puts on both companies in the event of a bankruptcy filing that extend through January. I'm short LYV with some call options at $55 for a weird looking straddle.
Big PFE news. The US has ordered 100 million doses of its vaccine.
Here's my take on the vaccine. Moderna and Regeneron are up something like 300 and 400% on the year. Neither have a single product and both have some spectacular market caps. If either fail those companies could get wiped out. If they succeed then it's already baked in.I think i read that it’s an almost $2 billion contract.
As i type this , PFE is only $38 a share.. i wonder if it wouldnt be a bad idea to sort of ‘hedge one’s bet’ by buying into Pfizer, Moderna and AstraZeneca, the three most promising vaccines I’ve read about recently.. of course would probably lose your shirt on two out of three, but if one of those companies comes up with THE vaccine, then that would more than make up for it.. or is that a rookie mistake? Also, hopefully multiple companies will come up with successful vaccines, so there’s that.
The smart play was getting in on Moderna or Regeneron 3 months ago.
Here's my take on the vaccine. Moderna and Regeneron are up something like 300 and 400% on the year. Neither have a single product and both have some spectacular market caps. If either fail those companies could get wiped out. If they succeed then it's already baked in.
For PFE or AZN, they are such large companies that a successful vaccine only has so much of an impact on the stock.
I don't think there is going to be the global demand that most others think there will be. I'm guessing several other countries are really close to either getting a usable vaccine or stealing the technology. If I had to bet China and India will also have vaccines with the ability to outproduce at a lower cost than anything from US companies. There will also be a lot of pressure for US companies to not overcharge. In the end, we're probably going to end up with 4-5 vaccines from 4-5 different companies that all work with slightly different concepts. So if you take 360 million, assume 40% wont get the vaccine then it's going to leave a pool of about 200M people split between 4-5 different companies and it's likely to be a one time boom. Like everyone always says, the treatment is more valuable than the cure.
The smart play was getting in on Moderna or Regeneron 3 months ago.
That's why I was looking at PFE as a portfolio hold. That 4.19% dividend is solid, and you get some upside on the vaccine front. It's not a growth mover, but a nice portfolio long.